Alaunos Therapeutics (TCRT) Interest Expenses (2021 - 2023)
Alaunos Therapeutics (TCRT) reported Interest Expenses of $1.1 million for Q2 2023, up 44.32% on a YoY basis from $740000.0 in Q2 2022, and up 25.21% quarter-over-quarter from $853000.0 in Q1 2023.
Alaunos Therapeutics (TCRT) Interest Expenses (2021 - 2023) Analysis & Trends
Alaunos Therapeutics has reported Interest Expenses for 3 years, with the latest figure at $1.1 million in Q2 2023.
- For the quarter ending Q2 2023, Interest Expenses rose 44.32% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2024 stood at $1.1 million (down 67.45% YoY), and the FY2023 full-year result was $1.9 million, down 39.09% from the prior year.
- Interest Expenses for Q2 2023 stood at $1.1 million, up from $853000.0 in the prior quarter.
- The five-year high for Interest Expenses was $1.1 million in Q2 2023, with the low at $400000.0 in Q3 2021.
- Historically, Interest Expenses has averaged $774250.0 across 3 years, with a median of $772500.0 in 2021.
- The largest YoY upside for Interest Expenses was 100.0% in 2022 against a maximum downside of 19.19% in 2022.
- Alaunos Therapeutics' Interest Expenses stood at $745000.0 in 2021, then gained by 19.19% to $888000.0 in 2022, then increased by 20.27% to $1.1 million in 2023.
- The last three Interest Expenses figures came in at $1.1 million (Q2 2023), $853000.0 (Q1 2023), and $888000.0 (Q4 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | Alaunos Therapeutics | 4.31 Mn | 3.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 1.07 Mn |
| Jun 30, 2023 | 1.07 Mn |
| Mar 31, 2023 | 853,000.00 |
| Mar 31, 2023 | 853,000.00 |
| Dec 31, 2022 | 888,000.00 |
| Dec 31, 2022 | 888,000.00 |
| Sep 30, 2022 | 800,000.00 |
| Sep 30, 2022 | 800,000.00 |
| Jun 30, 2022 | 740,000.00 |
| Jun 30, 2022 | 740,000.00 |
| Mar 31, 2022 | 700,000.00 |
| Mar 31, 2022 | 700,000.00 |
| Dec 31, 2021 | 745,000.00 |
| Dec 31, 2021 | 745,000.00 |
| Sep 30, 2021 | 400,000.00 |
| Sep 30, 2021 | 400,000.00 |